Grantham, Mayo, Van Otterloo & Co (GMO)’s Adtran ADTN Stock Holding History
Bought
Maintained
Sold
Other funds holding ADTN
SSA
NIM
Grantham, Mayo, Van Otterloo & Co (GMO)'s ADTN Position: Q2 2023 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Adtran (ADTN) in Q2 2023, closing a stake of 217,989 shares — an estimated $3.46M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ADTN in Q4 2017 and held it in 20 quarters. The position peaked at $5.95M in Q3 2019. 165 funds tracked by Wall St. Rank hold ADTN as of Q2 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Adtran position as of Q2 2023 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 217,989 Adtran shares in Q2 2023, an estimated $3.46M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Adtran in Q4 2017 and held it in 20 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Adtran position peaked at $5.95M in Q3 2019.
- 165 funds tracked by Wall St. Rank held Adtran as of Q2 2023.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2023, filed 14 Aug 2023.